4//SEC Filing
Boylan James P 4
Accession 0001171843-24-001275
CIK 0001738021other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 10:12 AM ET
Size
6.0 KB
Accession
0001171843-24-001275
Insider Transaction Report
Form 4
Boylan James P
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-03-08+40,000→ 40,000 totalExercise: $1.96Exp: 2034-03-07→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]The options vest over 48 substantially equal monthly installments starting April 8, 2024.
- [F2]The Reporting Person is a member of Enavate Sciences, LP ("Enavate"). Pursuant to an agreement with Enavate, the Reporting Person has agreed to receive and hold for the benefit of Enavate any securities issued under any stock options or other awards granted to him for his services as a director on the Issuer's board of directors. As such, the Reporting Person disclaims beneficial ownership of, and all right, title and interest in, the reported securities.
Documents
Issuer
Compass Therapeutics, Inc.
CIK 0001738021
Entity typeother
Related Parties
1- filerCIK 0001953094
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 10:12 AM ET
- Size
- 6.0 KB